MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Blood
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

10,018 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
10,018 works in the cohort · of 4,299,418page 24 of 201

Labels cover 11 of 10,018 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 10,018 of 10,018 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

afffundunlabeled
Quantitation of anti–factor VIII antibodies in human plasma
Jolanta Krudysz-Amblo, Behnaz Parhami-Seren, Saulius Butenas, Kathleen E. Brummel‐Ziedins, Edward D. Gomperts, Georges E. Rivard +1 more
2009· article· en· Blood· Medicine
machine prediction:candidate · noneconsensus · none
62
citations
affunlabeled
First Analysis of the Completed Mabthera International (Mint) Trial in Young Patients with Low-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Addition of Rituximab to a CHOP-Like Regimen Significantly Improves Outcome of All Patients with the Identification of a Very Favorable Subgroup with IPI=O and No Bulky Disease.
Michael Pfreundschuh, Lorenz Truemper, Devinder Gill, Anders Österborg, Ruth Pettengell, Marek Trněný +4 more
2004· article· en· Blood· Medicine
machine prediction:candidate · noneconsensus · none
61
citations
afffundno abstractunlabeled
Clonal hematopoiesis in sickle cell disease
Thomas Pincez, Simon Lee, Yann Ilboudo, Michael Preuß, Anne-Laure Pham Hung d’Alexandry d’Orengiani, Pablo Bartolucci +6 more
2021· letter· en· Blood· Medicine
machine prediction:candidate · noneconsensus · none
61
citations
affunlabeled
Effect of FCGR2A and FCGR3A variants on CLL outcome
David Dornan, Olivia Spleiss, Ru-Fang Yeh, Guillemette Duchâteau-Nguyen, Annika Dufour, Jianguo Zhi +15 more
2010· article· en· Blood· Medicine
machine prediction:candidate · noneconsensus · none
60
citations
afffundunlabeled
HES1 is a novel interactor of the Fanconi anemia core complex
Cédric S. Tremblay, Feng Huang, Ouassila Habi, Caroline Huard, Chantal Godin, Georges Lévesque +1 more
2008· article· en· Blood· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
60
citations

How this was built: Screen · Findings · About